Recent news on

Protherics PLC announces Regulatory Application  -  Jan 7, 2007
Genetic Engineering News (press release),Glenveigh is currently undertaking a phase 2b study with Digibind(R) which Protherics expects to report in 2007. Following the recent acquisition of

Protherics PLC - EGM Statement  -  Jan 3, 2007
SYS-CON Media,Glenveigh is currently undertaking a phase 2b study with Digibind® which Protherics expects to report in 2007. Subject also to Admission, the MacroMed

Protherics PLC - Result of Placing  -  Jan 2, 2007
Genetic Engineering News (press release),Glenveigh is currently undertaking a phase 2b study with Digibind(R) which Protherics expects to report in 2007. Subject also to the approval of

Protherics PLC announces GBP 38 million Fundraising  -  Dec 8, 2006
Genetic Engineering News (press release),Both Digibind(R) and DigiFab(R) are approved in the US for the treatment of life-threatening digoxin overdose and are generally considered clinically

GSK Acquiring Young Antibody Firm Domantis For $454M Cash  -  Dec 8, 2006
BioWorld Online,NC, relating to the use of ovine polyclonal antibody fragments (including DigiFab and GlaxoSmithKline's Digibind) for pre-eclampsia and eclampsia.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional